Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone in Cirrhotic Hypotensive Patients with Sepsis
NCT02602210Phase 3Terminated
- Sponsor
- UZ Leuven
- Start
- Jan 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of hydrocortisone in septic shock, sponsored by UZ Leuven. Started Jan 2015; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02602210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02602210.